Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder

Objective: The purpose of this open-label study was to examine the effects of long-acting methylphenidate (MPH) treatment on irritability and related emotional symptoms associated with disruptive mood dysregulation disorder (DMDD) in youth with comorbid attention-deficit/hyperactivity disorder (ADHD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Child Adolesc Psychopharmacol
Autors principals: Winters, Drew E., Fukui, Sadaaki, Leibenluft, Ellen, Hulvershorn, Leslie A.
Format: Artigo
Idioma:Inglês
Publicat: Mary Ann Liebert, Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6016730/
https://ncbi.nlm.nih.gov/pubmed/29708762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2017.0124
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars